Literature DB >> 8227091

Characterization and chromosomal mapping of the human thromboxane A2 receptor gene.

R M Nüsing1, M Hirata, A Kakizuka, T Eki, K Ozawa, S Narumiya.   

Abstract

The human thromboxane A2 gene, present as a single copy, spans over 15 kilobases (kb) and contains 3 exons divided by 2 introns. The first intron, intron 1, exists in the 5'-noncoding region, 83 base pairs upstream from the ATG start site and is 6.3 kb long. Intron 2 with a length of 4.3 kb is located at the end of the sixth transmembrane region, thereby separating it from the downstream coding sequences including the seventh transmembrane region and the 3'-untranslated region. By rapid amplification of 5'-cDNA ends, transcription initiation sites starting in two different putative promoter regions were determined. In the 5'-flanking region of these transcription initiation sites, no typical TATA box exists. The major promoter, the promoter region I, contains four potential SP-1 binding sites and several potential binding sites for other transcription factors. By polymerase chain reaction analysis, a small portion of the RNA transcribed from this gene was shown to contain an additional 115-base pair long noncoding exon, exon 1b, which is located in intron 1. No additional exon in intron 2 was detectable, indicating that a single type of thromboxane A2 receptor protein is encoded by this gene. Chromosomal localization was carried out by fluorescence in situ hybridization of cloned genomic DNA to the metaphase chromosome. The gene was assigned to 19p13.3 of human chromosome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227091

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.

Authors:  D W Thomas; R B Mannon; P J Mannon; A Latour; J A Oliver; M Hoffman; O Smithies; B H Koller; T M Coffman
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

Review 2.  Antiplatelet therapy: targeting the TxA2 pathway.

Authors:  P Fontana; A Zufferey; Y Daali; J-L Reny
Journal:  J Cardiovasc Transl Res       Date:  2013-12-19       Impact factor: 4.132

3.  Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan.

Authors:  S D Katugampola; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

4.  Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.

Authors:  A H Krauss; D F Woodward; L L Gibson; C E Protzman; L S Williams; R M Burk; T S Gac; M B Roof; F Abbas; K Marshall; J Senior
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

5.  Characterization of the gene for the mouse prostaglandin E receptor subtype EP2: tissue-specific initiation of transcription in the macrophage and the uterus.

Authors:  M Katsuyama; Y Sugimoto; K Okano; E Segi; R Ikegami; M Negishi; A Ichikawa
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

6.  Characterization of endothelial thromboxane receptors in rabbit aorta.

Authors:  Sandra L Pfister
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-09-02       Impact factor: 3.072

7.  Association of thromboxane A2 receptor gene polymorphisms with cerebral infarction in a Chinese population.

Authors:  Jing Zhao; Lan Zheng; Qingzhou Fei; Yi Fu; Yingfeng Weng; Hui Wu; Huanyin Li; Qi Jun; Jingshan Shao; Yuming Xu
Journal:  Neurol Sci       Date:  2013-03-02       Impact factor: 3.307

8.  Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene.

Authors:  M Hirata; A Kakizuka; M Aizawa; F Ushikubi; S Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

9.  Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder.

Authors:  T Hirata; A Kakizuka; F Ushikubi; I Fuse; M Okuma; S Narumiya
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

10.  Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide.

Authors:  Katarina Wikström; David J Kavanagh; Helen M Reid; B Therese Kinsella
Journal:  Cell Signal       Date:  2008-05-23       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.